Company intelligence / Profile preview

EloCare

Ownership: Private
Development stage: Commercial

Overview

EloCare has developed the first menopause tracker—a wearable device paired with a mobile app that monitors symptoms through biomarkers and self-assessments to provide lifestyle and medical suggestions. The solution is being co-developed with clinicians, has won several innovation awards, and is being piloted with major Singaporean healthcare providers.

Therapeutic areas: NeurologyWomen's Health
Modalities: DeviceMobile app
Industry: Physiological Monitoring

Partnerships

National Healthcare Group (NHG), SingaporeSt Luke's ElderCare (SLEC), SingaporeMedTech Actuator programEnterprise Singapore Open Innovation Challenge partners

Beyond the preview

Go deeper on EloCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EloCare.

Explore the full profile